BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2019
View Archived Issues
Getting ncAAs ready for playoffs
Read More
LRG as a novel biomarker to monitor the efficacy of adalimumab treatment in UC and CD
Read More
Long, low growth factor signaling promotes healing
Read More
Glutamine blockade: Bad for tumor cells, good for T cells
Read More
Cerecor announces milestones in clinical development programs of CERC-301 and CERC-802
Read More
FDA clears IND application for ACH-5228
Read More
Indalo Therapeutics presents first clinical data for IDL-2965
Read More
Topline phase II data presented for TNP-2092
Read More
Turning Point Therapeutics initiates phase I/II trial of TPX-0046
Read More
SAR-20351 demonstrates promising safety and efficacy in syngeneic tumor models
Read More
MRX-1669, a novel small-molecule Myc inhibitor with promising in vitro activity
Read More
ALBI as a promising prognostic marker in predicting survival from HCC
Read More
HOOKIPA Pharma presents phase I data for CMV vaccine HB-101
Read More
Emergex Vaccines descibes new filovirus vaccines
Read More
Seres Therapeutics discloses bacterial compositions
Read More
Dopamine D1 receptor positive allosteric modulators discovered at Lilly
Read More
Baylor College of Medicine, Tvardi Therapeutics patent STAT3 inhibitors
Read More
Medshine Discovery identifies new LRRK2 inhibitors
Read More
Phase IIa data for multiple doses of GSK-3389404 in chronic HBV on stable nucleos(t)ide therapy
Read More
IL-7- and/or IL-12-expressing oncolytic viruses enhance antitumor immune responses in mice
Read More
New immunotherapy delivering previously encountered antigenic peptides leads to anticancer response
Read More
New anti-CD147 antibodies induce SMAD and JNK signaling and tumor shrinkage in xenograft models
Read More
New technology improves prediction of liver toxicity
Read More
Phase III portion of CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint
Read More
European Commission grants conditional marketing authorization to Ebola Zaire vaccine Ervebo
Read More
Otsuka and Avanir decide to continue development of AVP-786 for agitation in Alzheimer's dementia
Read More